Behavioral Economics Matters for HIV Research: The Impact of Behavioral Biases on Adherence to Antiretrovirals (ARVs).
Behavioral Economics Matters for HIV Research: The Impact of Behavioral Biases on Adherence to Antiretrovirals (ARVs).
复制标题
DOI：
10.1007/s10461-015-1076-0
复制
发表时间：
2015-11
影响因子：
4.4
通讯作者：
Stecher C
中科院分区：
文献类型：
--
作者：
Linnemayr S;Stecher C
行为经济学（BE）已被用于研究许多健康行为，如吸烟和吸毒，但人们对这些见解如何与艾滋病毒预防和护理联系起来知之甚少。我们在155名乌干达艾滋病患者中提出了新的证据，证明了当前偏见、过度乐观和信息突出等常见行为决策错误的流行，并分析了它们与随后的药物依从性的关系。36%的研究参与者被归类为当前偏见，21%的人被归类为过度乐观，34%的人被归类为具有突出的艾滋病毒信息。表现出当前偏见的患者依从率高于90%的可能性降低了13% (p = 0.006)，过于乐观的患者依从率降低了9% (p = 0.04)，而那些没有显著艾滋病毒信息的患者依从率降低了17% （p < 0.001）。这些发现表明，BE可用于筛选未来的依从性问题，并更好地设计和目标干预措施，以解决这些行为偏差和相关的次优依从性。
Behavioral economics (BE) has been used to study a number of health behaviors such as smoking and drug use, but there is little knowledge of how these insights relate to HIV prevention and care. We present novel evidence on the prevalence of the common behavioral decision-making errors of present-bias, overoptimism, and information salience among 155 Ugandan HIV patients, and analyze their association with subsequent medication adherence. 36 % of study participants are classified as present-biased, 21 % as overoptimistic, and 34 % as having salient HIV information. Patients displaying present-bias were 13 % points (p = 0.006) less likely to have adherence rates above 90 %, overoptimistic clients were 9 % points (p = 0.04) less likely, and those not having salient HIV information were 17 % points (p < 0.001) less likely. These findings indicate that BE may be used to screen for future adherence problems and to better design and target interventions addressing these behavioral biases and the associated suboptimal adherence.